Multivitamins against ageing? What the Nature study actually reveals

A major US research project has been attracting plenty of attention: multivitamin supplements might measurably slow biological ageing in later life. The paper, published in Nature Medicine, initially sounds like the perfect news for anyone hoping to stay healthy for longer. A closer look, however, paints a much more restrained picture.

What the COSMOS project is about

The study is called COSMOS - short for “Cocoa Supplement and Multivitamin Outcomes Study”. It was led by a well-established team at Brigham and Women’s Hospital in Boston, known for work in preventive medicine and longevity research.

Almost 1,000 people aged 70 and over took part, with women and men represented in roughly equal numbers. For two years, everyone swallowed capsules daily without knowing what they contained. Participants were randomly assigned to one of four groups:

• multivitamin supplement plus 500 mg cocoa powder with 50 mg epicatechin
  
• cocoa only plus placebo
  
• multivitamin only plus placebo
  
• placebo only
  

The researchers set out to answer two practical questions: do cocoa antioxidants deliver measurable health benefits in older age? And can a standard, off-the-shelf multivitamin influence the ageing process?

Epigenetic clocks: how old is the body, biologically?

Instead of relying purely on blood markers or counting diagnoses, the team used a newer tool: “epigenetic clocks”. These are based on small chemical tags on genetic material - especially methyl groups attached to DNA. Such patterns shift over the lifespan and can be statistically linked to mortality and disease risk.

At baseline, then again at 12 and 24 months, the scientists measured DNA methylation using five established epigenetic clocks. The goal was to see whether any of the supplements slowed biological ageing.

The central finding was this: people who took a multivitamin for two years showed, on average, slightly slower epigenetic ageing than those who took a placebo.

Put numerically, the gap was roughly equivalent to a four‑month “advantage” in biological youthfulness compared with the placebo group - over the two-year study period.

COSMOS multivitamin results: an effect, while cocoa shows no measurable benefit

One of the more striking outcomes concerns cocoa. Despite its reputation as a “superfood” because of its antioxidant content, cocoa produced no detectable improvement in epigenetic age in this analysis. The trajectories for the cocoa groups did not differ meaningfully from placebo.

The multivitamin groups, by contrast, stood out: across all five epigenetic signatures, the direction of change consistently suggested slower ageing. The clearest signal appeared in two clocks that are particularly closely associated with mortality.

Those who benefited most were participants who already showed evidence of accelerated biological ageing at the start. In that subgroup, the supplement measurably dampened that acceleration. That does not make it a fountain of youth - rather, it points to a modest slowdown that is statistically detectable but not something most people would feel day to day.

What the researchers themselves caution

If you only skim headlines, you might come away thinking: “Multivitamins erase wrinkles.” The paper does not support that kind of simplification. The authors are notably careful in their wording, describing statistically significant but limited effects and explicitly calling for more research.

It remains unresolved whether this small improvement in epigenetic age translates into fewer diseases, longer life, or a better quality of life.

There is also a broader issue: although epigenetic clocks are seen as promising longevity markers, they are not an officially accepted gold standard. The link between these readings and concrete outcomes such as heart attack, cancer, or dementia is still far from fully established.

Multivitamins versus a healthier diet - the comparison we still do not have

The researchers highlight a question that matters most in everyday life: no-one yet knows how a multivitamin compares with a sustained shift towards a healthier diet. Would the effect be similar, smaller, or even unnecessary if someone ate plenty of vegetables, wholegrains and pulses while limiting highly processed foods?

That head-to-head comparison is missing. This was a “supplement versus placebo” trial - not “supplement versus dietary change”.

Industry funding - how independent are the findings?

Another point sits in the small print: funding. Alongside public bodies such as the National Institutes of Health, several private sponsors with commercial interests in supplements were involved.

• Mars Edge, the nutrition arm of confectionery group Mars, supplied products.
  
• Pfizer Consumer Healthcare (now Haleon) took part - a major provider of over‑the‑counter supplements.
  
• Foxo Technologies supported the epigenetic testing.
  
• The American Pistachio Growers and the Council for Responsible Nutrition (a supplement-industry association) were listed as additional partners.
  

The researchers state that sponsors did not influence the work and that they see no conflicts of interest. Formally, that may be correct. Even so, the lingering question remains: would the same results have been accepted more readily without industry-linked sponsorship? Probably.

What this could mean for everyday life in older age

The trial clearly targets people aged 70 and above. In this age group, shortfalls in certain vitamins and trace elements are common - for example vitamin D, B12 or folate. In that context, a multivitamin may act as a safety net that helps to correct mild deficiencies.

Whether the small slowing of epigenetic ageing ultimately translates into meaningful differences in health or lifespan is unknown. Someone who is already well supplied is likely to gain far less than someone with proven deficiencies.

Question	What the study suggests
Does a multivitamin slow biological ageing?	Yes, slightly - as measured by epigenetic clocks.
Would you notice the effect in daily life?	Unclear at present; the benefit is small.
Can a supplement replace a healthy diet?	No, there is no evidence for that.
Are there conflicts of interest?	Several industry sponsors were involved.

How to interpret studies like this properly

Acting on health headlines can easily lead you astray. A quick reality check is more useful:

• Was the study randomised and placebo-controlled? Yes - a genuine strength here.
  
• How big is the effect? In this project, it is modest rather than life-changing.
  
• Is the measure directly relevant to real life? Epigenetic clocks are intriguing, but they do not replace hard disease outcomes.
  
• Who paid for it? Industry funding does not automatically mean manipulation, but it does warrant extra scrutiny.
  

Keeping these questions in mind makes it harder to be swayed by marketing promises or overstated headlines.

Multivitamins, risks, and sensible approaches

For most older adults, standard multivitamins at moderate doses are relatively safe. Problems tend to arise when people stack multiple products and inadvertently take too much - particularly of fat-soluble vitamins such as A or E.

A sensible approach looks like this: first, discuss with a doctor whether specific deficiencies are present, then supplement in a targeted way. A blood test is usually far more informative than choosing something from a pharmacy shelf.

Alongside that, the biggest levers against accelerated ageing remain the familiar basics:

• plenty of vegetables, fruit, pulses and wholegrains
  
• regular movement, ideally including some strength training within your abilities
  
• avoiding tobacco and taking care with alcohol
  
• adequate sleep and maintaining social connections
  

Supplements can play a supporting role, but they are rarely the first step. The COSMOS results hint that a multivitamin in later life might nudge the body’s internal ageing pace very slightly. Whether that theoretical edge leads to more healthy years is something future research still needs to demonstrate.